All In MedTech

FDA Clearance Tracker · P010014-S014

OXFORD UNICOMPARTMENTAL KNEE SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 5, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 5, 2011

Approved

Time to decision

1,683 days

Received Dec 26, 2006. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P010014-S014
Device name
OXFORD UNICOMPARTMENTAL KNEE SYSTEM
Applicant location
Warsaw, IN
Received
Dec 26, 2006
Decided
Aug 5, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P010014

Device type

Device class
Class III

Every decision under product code NRA

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MANUFACTURING SITES LOCATED AT BIOMET ORTHOPEDICS, INC., IN WARSAW, INDIANA, AND STERIS INC., LOCATED AT ISOMEDIX SERVICES, IN LIBERTYVILLE, ILLINOIS.

Source documents

Other decisions for Biomet Manufacturing Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.